The South African Health Products Regulatory Authority - SAHPRA - has made the decision to withdraw pholcodine-containing medicines from the South African market due to the increased risk of sudden, severe, and life-threatening allergic reactions occurring during surgery. Pholcodine has been used as a cough suppressant since the 1950s. It is registered to treat dry coughs and is available in various non-prescription medicines. Sebenzile Nkambule spoke to Mafora Matlala, Pharmacovigilance Manager at Sahpra

Parliament says it's ready to host the six day 69-the Commonwealth conference
03:03

Eastern Cape residents frustration following the municipality's decision to spend 235-thousand rand on a State of the Metro Address event
03:36

Gauteng Education Department intensifying its crackdown on illegally operating independent schools across the province
03:30